HomeMRVL • CVE
add
Marvel Biosciences Corp
Previous close
$0.16
Day range
$0.16 - $0.16
Year range
$0.075 - $0.40
Market cap
9.28M CAD
Avg Volume
40.44K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 488.69K | 47.62% |
Net income | -1.19M | -101.17% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 128.86K | -62.73% |
Total assets | 326.72K | -33.50% |
Total liabilities | 4.33M | 30.62% |
Total equity | -4.01M | — |
Shares outstanding | 58.00M | — |
Price to book | -2.00 | — |
Return on assets | -295.38% | — |
Return on capital | 83.91% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Net income | -1.19M | -101.17% |
Cash from operations | -330.14K | 3.06% |
Cash from investing | — | — |
Cash from financing | 69.98K | -85.07% |
Net change in cash | -260.16K | -303.13% |
Free cash flow | -146.48K | 22.16% |
About
Founded
2021
Headquarters
Website
